產(chǎn)品基本信息
產(chǎn)品編號(hào)：C377832
產(chǎn)品名稱：5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid-13C,d7
產(chǎn)品CAS：
規(guī)格含量：10mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
C377832
名稱:
5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid-13C,d7
別名:
1-(2,4-Dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic Acid-13C,d7 ; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic Acid-13C,d7;
參考CAS:
162758-35-2-未標(biāo)記
分子式:
C??¹³CH?D?Cl?N?O?
分子量:
389.68
類別:
Building Blocks; Isotopic Labeled Analogues;
應(yīng)用:
Labelled 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic Acid is used in the preparation of biarylpyrazole based derivatives as cannabinoid CB1 receptor antagonists. It is labelled metabolite M9 of Rimonabant (R517802), an antiobesity agent.
參考文獻(xiàn)
Kang, S.Y. et al.: Bioorg. Med. Chem. Lett., 18, 2385 (2008); Fulp, A. et al.: Bioorg. Med. Chem. Lett., 21, 5711 (2011); Bergstrom, M.A. et al., Drug Metabolism and Disposition 39, 1823 (2011).
?您的位置：
